Dr. Ravneet Thind, MD

Dr. Thind practices at UK St. Claire Regional Medical Center in Morehead, Kentucky, part of UK Healthcare.

Dr. Thind's NPI, 1215146378, was assigned on May 22, 2007. Dr. Thind holds Kentucky license 47826.

Dr. Thind's primary practice is UK St. Claire Regional Medical Center, at 222 Medical Circle, Morehead, KY 40351 in Rowan County. The practice phone is (606) 783-6500.

Dr. Thind's primary practice is UK St. Claire Regional Medical Center in Morehead, Kentucky, part of UK Healthcare. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Thind to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thind practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Thind's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Thind is licensed in Kentucky.

CMS data shows 614 Medicare services from Dr. Thind across 3 procedure codes in 2024, for 190 Medicare patients. Medicare paid $39,227 for them.

CMS counts 190 Medicare patients who saw Dr. Thind in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thind's median patient age at 67, with 60% women.

In 2024, Dr. Thind wrote 826 Medicare Part D claims for 165 patients. 81% of them were for generic drugs. CMS names the drug for 683 of them, across 23 drugs with 11 or more claims each, at $980,185 in total drug cost. In 2023, CMS named 378 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Thind for performance year 2024, reported as part of a group. Dr. Thind accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thind as offering telehealth.

Dmand AI links 2 papers to Dr. Thind, published from 2023 to 2024. The most frequent topics are Lung Neoplasms and Palliative Care. Dr. Thind has published most often in Support Care Cancer. Dr. Thind's most frequent co-authors are David Kendall Goebel, MD, Jessica Mai McFarlin, MD and Laura M. Trice, MD.

Dmand AI links Dr. Thind to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 461 general payments to Dr. Thind from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $2,695.